Volume 25, Number 3—March 2019
Dispatch
Neutralizing Antibody against Enterovirus D68 in Children and Adults before 2014 Outbreak, Kansas City, Missouri, USA1
Table
Age group, y | No. | % Neutralizing antibody positive; median (range) neutralizing antibody titer* |
|||
---|---|---|---|---|---|
Fermon | 14-18949 | 14-18952 | 14-18953 | ||
2–5 | 79 | 100; 5.50 (3.17–9.5) | 100; 5.83 (3.5–10.5) | 60; 3.17 (2.5–10.5) | 81; 4.17 (2.5–10.5) |
6–10 | 97 | 100; 6.17 (3.17–10.5) | 100; 7.83 (4.17–10.5) | 89; 7.83 (2.5–10.5) | 83; 6.17 (2.5–10.5) |
11–15 | 91 | 100; 5.83 (3.17–10.5) | 100; 7.83 (3.17–10.5) | 97; 8.50 (2.5–10.5) | 93; 6.50 (2.5–10.5) |
16–50 | 84 | 100; 8.50 (3.83–10.5) | 100; 8.50 (4.83–10.5) | 98; 9.17 (2.5–10.5) | 96; 7.17 (2.5–10.5) |
>50 |
85 |
100; 10.50 (6.5–10.5) |
100; 8.83 (4.83–10.5) |
99; 9.50 (2.5–10.5) |
98; 6.83 (2.5–10.5) |
Total | 436 | 100; 6.83 (2.83–10.5) | 100; 7.83 (3.5–10.5) | 89; 8.34 (2.5–10.5) | 91; 6.50 (2.5–10.5) |
*Antibody titers were measured by using the cell viability kit ATPlite (Perkin Elmer, http://www.perkinelmer.com); the titers shown are the log2 inverse dilution of the lowest antibody concentration with luminescent activity.
1Preliminary results from this study were presented at the Clinical Virology Symposium, May 19–22, 2016, Daytona Beach, Florida, USA.
2These authors contributed equally to this article.
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.